Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety of Decade Plus Use of IgPro20 in the Real World: Post-marketing Pharmacovigilance Report

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States